Site Reference ID/Investigator# 61522 — Hackensack, New Jersey

Site Reference ID/Investigator# 61522 is a clinical research site located in Hackensack, New Jersey, United States 07601.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site Reference ID/Investigator# 61522 has participated in 1 clinical trials.

Therapeutic areas: B-cell Small Lymphocytic Lymphoma Recurrent.

Sponsors: Aptevo Therapeutics.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Reference ID/Investigator# 61522?

Site Reference ID/Investigator# 61522 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Reference ID/Investigator# 61522 conducted?

Site Reference ID/Investigator# 61522 has 1 clinical trials on record. Their work covers B-cell Small Lymphocytic Lymphoma Recurrent.

Is Site Reference ID/Investigator# 61522 accredited by Crixeo Health?

Site Reference ID/Investigator# 61522 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Reference ID/Investigator# 61522?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.